Eric Fink

Eric Fink serves as Chief People Officer for IRulya Therapeutics, where he leads the company’s people strategy, organizational design, talent, and total rewards functions. He brings more than 25 years of experience in human resources and operational leadership across the life sciences industry, with a track record of building and scaling organizations from clinical-stage start-ups through commercial-stage, publicly traded enterprises.Before joining IRulya, Mr. Fink served as Chief Operating Officer of a Boston-based life sciences investment and incubation company, where he built and oversaw G&A and operating functions across a portfolio of clinical-stage biotechs.Earlier in his career, he served as Chief Human Resources Officer at three NASDAQ-listed biopharmaceutical companies, including Global Blood Therapeutics (NASDAQ: GBT, acquired by Pfizer), where he was selected as the organization’s first CHRO to lead the people, capability, and governance work required to scale globally. He spent nearly a decade at Jazz Pharmaceuticals (NASDAQ: JAZZ) in roles of increasing responsibility, including Vice President, Human Resources, and previously held commercial roles at Bayer HealthCare and GlaxoSmithKline. Mr. Fink earned his Master of Science in Organizational Leadership from Mercyhurst College and his Bachelor of Science in Biology from Pennsylvania State University, and holds the Senior Certified Professional designation through the Society for Human Resource Management (SHRM-SCP).